Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NTRA
NTRA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NTRA News
Signatera Test Shows Survival Benefits in Colorectal Cancer Patients
2d ago
Newsfilter
Natera and Aveta Partner for Phase 3 Clinical Trial of APG-157
Jun 29 2026
Newsfilter
Biotech Sector Update: FDA and EU Approvals
Jun 26 2026
NASDAQ.COM
Natera Partners with Eledon for Kidney Transplant Trial
Jun 26 2026
NASDAQ.COM
JGRO Stock Price Analysis and ETF Dynamics
Jun 25 2026
NASDAQ.COM
Natera Partners with Eledon for Kidney Transplant Trial Using Prospera Test
Jun 25 2026
NASDAQ.COM
Natera's Cancer Test Approved in Japan
Jun 24 2026
seekingalpha
First PMDA-Approved MRD Test Launched in Japan
Jun 24 2026
Newsfilter
NCCN Recognizes Signatera for Bladder Cancer Treatment
Jun 23 2026
Newsfilter
Natera Showcases New Prospera Test Data at American Transplant Congress
Jun 18 2026
Newsfilter
NTRA Stock Shows Potential for Breakout
Jun 17 2026
CNBC
U.S. Government May Challenge IARC Cancer Assessments
Jun 08 2026
seekingalpha
JGRO Stock Price Analysis and ETF Dynamics
Jun 05 2026
NASDAQ.COM
Stanley Druckenmiller Invests in Natera
Jun 03 2026
Fool
Natera Partners with Diakonos to Evaluate New Therapy
May 29 2026
Newsfilter
Natera Initiates SIGNAL-ER 101 Study for Early-Stage Breast Cancer
May 28 2026
NASDAQ.COM
Show More News
